059-12 Wyo. Code R. §§ 12-16 - Parenteral Medications
(a) The PIC shall
be responsible for the preparation, sterilization, labeling, and dispensing of
parenteral medications prepared within the institutional facility and shall
participate in the education and training, including the provision of
appropriate incompatibility information, of all personnel involved in the
preparation of parenteral medications.
(b) If intravenous admixtures are prepared
within the institutional facility, the institutional pharmacy shall have
adequate equipment, personnel, and space for such preparation. The compounding
and labeling of intravenous admixtures, including all total parenteral
nutrition, shall be performed by, or under, the direct supervision of a
pharmacist; however, if twenty-four hour (24-hour) pharmacy service is not
provided at the institutional facility, the PIC shall establish written
policies and procedures to be followed in the preparation of intravenous
admixtures when the institutional pharmacy is closed or in emergency
situations.
(c) All admixtures
shall be labeled with a distinctive supplementary label, indicating the name
and amount of drug added, date and time of addition, beyond use date, and rate
of administration, and the name or identification code of the person adding the
drug.
(d) The PIC shall be
responsible for removing concentrated electrolytes (including, but not limited
to: potassium chloride, potassium phosphate, sodium chloride greater than 0.9%)
from patient care areas and limiting their access to pharmacists. If
twenty-four hour (24-hour) on-call status for pharmacists is not available, the
institutional facility must utilize the most trained professional available to
process concentrated electrolytes. Training in the safe use of concentrated
electrolytes should be conducted by the institutional pharmacy for
non-pharmacist staff with access to concentrated electrolytes. Evidence of
training will be documented and retrievable, and the institutional facility
will have policies and procedures that detail this process. Premixed large
volume intravenous solutions containing electrolytes and premixed potassium
bolus doses will be used whenever possible.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.